| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -5.1e-05 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -2.1e-05 | 1 |